DarioHealth Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the U.S. Securities and Exchange Commission on November 12, 2026, disclosing condensed consolidated interim financial statements and related management discussion.

Key Highlights

  • Shares outstanding: As of November 12, 2026, the registrant had 11,287,022 shares of common stock outstanding.
  • Total assets: Total assets were $112,432 thousand as of September 30, 2026, compared to $110,075 thousand as of December 31, 2025.
  • Cash and cash equivalents: Cash and cash equivalents were $27,844 thousand as of September 30, 2026, up from $21,803 thousand at December 31, 2025.
  • Goodwill: Goodwill was reported at $57,427 thousand at both September 30, 2026 and December 31, 2025, unchanged between periods.
  • Intangible assets, net: Intangible assets, net were $14,526 thousand at September 30, 2026, down from $15,931 thousand at December 31, 2025.
  • Total current assets: Current assets totaled $38,486 thousand at September 30, 2026, compared to $35,067 thousand at December 31, 2025.
  • Filer classification: The registrant identified itself as a non-accelerated filer and a smaller reporting company.

DarioHealth Balance Sheet and Filing Details for the Quarter Ended September 30, 2026

DarioHealth Corp., listed on NASDAQ:DRIO, submitted this quarterly report covering the three-month period ended September 30, 2026. According to the filing, total assets reached $112,432 thousand at quarter end, an increase from $110,075 thousand reported at December 31, 2025. The company's current assets grew to $38,486 thousand from $35,067 thousand over the same interval, with cash and cash equivalents rising to $27,844 thousand from $21,803 thousand. Short-term bank deposits stood at $3,309 thousand, while trade receivables, net were $1,449 thousand, compared to $2,144 thousand at year-end 2025.

Non-current assets, according to the filing, totaled $73,946 thousand at September 30, 2026, down from $75,008 thousand at December 31, 2025. Goodwill remained unchanged at $57,427 thousand across both periods. Intangible assets, net declined to $14,526 thousand from $15,931 thousand. Inventories were $3,538 thousand at the quarter end, compared to $4,316 thousand at year-end 2025. Property and equipment, net stood at $479 thousand, down from $549 thousand at December 31, 2025.

The filing notes that forward-looking statements in the quarterly report reflect the company's current expectations and projections, and are subject to risks and uncertainties described in the company's Annual Report on Form 10-K for the year ended December 31, 2025. The company stated it undertakes no obligation to update forward-looking statements except as required by federal securities laws. DarioHealth identified its principal executive offices at 322 W. 57th St. #33B, New York, New York 10019.

What Was Disclosed

DarioHealth Corp. disclosed condensed consolidated interim balance sheet data for September 30, 2026, showing total assets of $112,432 thousand and 11,287,022 shares of common stock outstanding as of November 12, 2026, alongside a cautionary note regarding forward-looking statements.